Consumer

American Premium Water Corp. (OTC: HIPH) Announces Expanded Distribution into Wal-Mart

PLAYA VISTA, CA, Jun 24, 2019 American Premium Water Corporation (OTC: HIPH) announces the distribution of Canyon Create’s varicose vein cosmetic treatment, Vanexxe, is now available for sale on Walmart.com (https://www.walmart.com/ip/Vanexxe-Varicose-Vein-Support-Gel/867729968). American Premium CEO, Ryan […]

Consumer

YIELD GROWTH (OTC: BOSQF) Announces 9 New Products for CBD Infusion Complete Stability Testing

Vancouver, British Columbia– The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3)announces that the following products containing hemp and other botanicals have completed stability and preservative challenge tests at a laboratory in British Columbia: Eye […]

Healthcare

FDA Grants Face-to-Face Meeting to Discuss CytoDyn’s (OTC: CYDY) 510(k) Application for ProstaGene(TM) Prognostic Test

VANCOUVER, Washington, June 24, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications today announced that […]

Newsmakers

Phunware (NASDAQ: PHUN) Announces Sale of Phun Utility Token to International Markets

Phunware, Inc. (NASDAQ: PHUN) (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, today announced Phun utility tokens are now available for purchase in select international markets. […]

Newsmakers

American Premium Water Corp (OTC: HIPH) Announces Restock of its Popular LALPINA CBD Water on SingleSeed.com

PLAYA VISTA, Jun 20, 2019 – American Premium Water Corporation HIPH, +1.85% (“the Company”) announces that is has sent restock shipments of its popular selling LALPINA Hydro CBD water to its online distribution partner SingleSeed (www.singleseed.com), a subsidiary […]

Healthcare

CytoDyn (OTC: CYDY) Submits 510(k) Pre-Submission Application to U.S. FDA for ProstaGene(TM) Prognostic Test

Dr. Richard Pestell, who leads CytoDyn’s cancer, NASH and GvHD programs, recently named to The Order of Australia, established by Queen Elizabeth II VANCOUVER, Washington, June 19, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the […]

Newsmakers

Phunware (NASDAQ: PHUN) Appoints Brittany Kaiser to Advisory Board

Cambridge Analytica whistleblower to facilitate global #OwnYourData initiatives in conjunction with Phunware MaaS ecosystem. Phunware, Inc. (NASDAQ: PHUN),  (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, […]

Business Services

GP Solutions (OTC: GWPD) Offers Financing So Businesses Can Quickly Get Up and Growing in the $992 Billion U.S. Agriculture Industry

Program provides a low-cost way for businesses to obtain the advanced GrowPod cultivation system CORONA, Calif., June 18, 2019– GP Solutions (OTC: GWPD) a leading developer of automated micro-farms, announced it is now offering financing to provide […]

Healthcare

CytoDyn (OTC: CYDY) Signs Groundbreaking Memorandum of Understanding with Thai Red Cross AIDS Research Centre to Study Pre-Exposure Prophylaxis Use of Leronlimab (PRO 140) in People at High Risk of Acquiring HIV

VANCOUVER, Washington, June 17, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today a Memorandum […]

Healthcare

CytoDyn Raises over $12 Million in New Capital from Private and Public Warrant Offers in the Last Five Weeks with Minimum Dilution

VANCOUVER, Washington, June 14, 2019  — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications announced today that it […]

Healthcare

CytoDyn (OTC: CYDY) to Present Pivotal Data at ASM Microbe 2019 Demonstrating Efficacy and Safety of Leronlimab (PRO 140) in HIV Patients with Multiple ARV Class Resistance

        VANCOUVER, Washington, June 13, 2019  — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications […]

Consumer

American Premium Water Corporation (OTC: HIPH) Retains PCAOB Accounting Firm Weinberg & Company to Initiate Audit

The Company expects to submit a Form 10 upon completion of audit with the eventual goal of uplisting to the NASDAQ PLAYA VISTA, Jun 12, 2019 – American Premium Water Corporation (OTC: HIPH) (“the Company”) announces […]

Newsmakers

YIELD GROWTH (OTC: BOSQF) Announces Launch of Urban Juve CBD Skin Essentials, a New Line of CBD-Infused Skin Care Products

Vancouver, British Columbia–( June 6, 2019) – The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to announce that its wholly owned subsidiary, Urban Juve, will be launching Urban Juve CBD Skin Essentials-a new […]